The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Clinicopathologic comparison of resected pulmonary adenocarcinoma according to the EGFR mutation status.
T. Yano
No relevant relationships to disclose
T. Yoshida
No relevant relationships to disclose
Y. Morodomi
No relevant relationships to disclose
K. Ito
No relevant relationships to disclose
A. Haro
No relevant relationships to disclose
Y. Shikada
No relevant relationships to disclose
R. Maruyama
No relevant relationships to disclose
M. Takenoyama
No relevant relationships to disclose
Y. Maehara
No relevant relationships to disclose